100s of titles, one news app for just $10 a month.
Dive Deeper:
Salarius Pharmaceuticals: Q1 Earnings Insights
Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Preview: Processa Pharmaceuticals's Earnings
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
A Preview Of TRACON Pharmaceuticals's Earnings
TRACON Pharmaceuticals (NASDAQ:TCON) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's…
One subscription that gives you access to news from hundreds of sites
A Preview Of Opiant Pharmaceuticals's Earnings
Opiant Pharmaceuticals (NASDAQ:OPNT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to…
Earnings Outlook For NovaBay Pharmaceuticals
NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Get all your news in one place
Latest Business news:
Home builder Metricon denies rumours of collapse as industry faces major cost blowouts
Home builders are being warned to expect higher costs and lengthy delays until at least 2023 as the construction industry…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Age of Scarcity Begins With $1.6 Trillion Hit to World Economy
New fault-lines are likely to outlast war and plague — leaving the global economy smaller and prices higher.
Sydney-based startup Space Machines Company partners with SpaceX
Sydney-based in-space logistics startup Space Machines Company has partnered with Elon Musk’s SpaceX to launch its spacecraft next year. Space…
How a Trash-Talking Crypto Bro Caused a $40 Billion Crash
Do Kwon, a trash-talking entrepreneur from South Korea, called the cryptocurrency he created in 2018 “my greatest invention.” In countless…
Google’s Russian business plans to file for bankruptcy
Google says its Russian subsidiary is planning to file for bankruptcy because it can't pay staff and suppliers. Russian state…
From analysis to good news, read the world’s best news in one place
SA moves to scrap tax on electric vehicles
South Australia's new Labor government has delivered on one of its election promises and moved to scrap plans for a…
Crypto billionaire Sam Bankman-Fried: ‘I got involved with no clue what a blockchain was’
The FTX founder on hype, the problem with bitcoin and how crypto can build a fairer financial system

Salarius Pharmaceuticals's Earnings: A Preview

By Benzinga Insights

Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.

Analysts estimate that Salarius Pharmaceuticals will report an earnings per share (EPS) of $-0.09.

Salarius Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.01, which was followed by a 26.62% drop in the share price the next day.

Stock Performance

Shares of Salarius Pharmaceuticals were trading at $0.1926 as of May 10. Over the last 52-week period, shares are down 84.27%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Salarius Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Salarius Pharmaceuticals: Q1 Earnings Insights
Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Preview: Processa Pharmaceuticals's Earnings
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
A Preview Of TRACON Pharmaceuticals's Earnings
TRACON Pharmaceuticals (NASDAQ:TCON) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's…
One subscription that gives you access to news from hundreds of sites
A Preview Of Opiant Pharmaceuticals's Earnings
Opiant Pharmaceuticals (NASDAQ:OPNT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to…
Earnings Outlook For NovaBay Pharmaceuticals
NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Get all your news in one place